Medtech Talk

“Assistive” devices are often bulky, but not the one Jeremiah Robison, founder and CEO of Cionic, has developed. His company’s FDA-cleared Neural Sleeve is worn on the leg and combines wearable sensors, machine learning, and functional electrical stimulation to improve gait for people dealing with foot drop, spasticity, and other mobility-limiting neurologic conditions. Host Geoff Pardo shares a very personal story of a spinal procedure that took away much of his right-side mobility and how the Neural Sleeve has helped with his recovery. Robison also shares the origins of the technology, starting with his daughter’s cerebral palsy diagnosis. Their conversation breaks down how the system works, including IMUs for gait kinematics, surface EMG for muscle signals, and why precise timing in the walking cycle changes everything. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare   

Cionic Links:
Cionic 

At this year’s Medtech MVP, a panel of industry experts explored how robotics are changing healthcare beyond the operating room. Robotic technologies are being deployed across inpatient care, rehabilitation, logistics, and remote patient support. Moderated by Virginia L. Giddings of Edwards Lifesciences, the panel includes Amanda Baumann of Stryker; Nir Goldenberg of Mayo Clinic Ventures; Kate Jackson Hobbs of Intuitive; and Maggie Nixon of Capstan Medical. Together they discuss the workforce, financial, and reimbursement considerations shaping adoption and how AI advancement will affect the future of robotics. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Medtech MVP

Edwards Lifesciences:
Edwards Lifesciences 

Stryker:
Stryker 

Mayo Clinic:
Mayo Clinic 

Intuitive:
Intuitive  

Capstan Medical:
Captstan Medical 

A discectomy can feel like instant relief until the pain comes back, and the “small” hole in the disc turns into a repeat surgery, degeneration, and lost mobility. Joining the podcast is Greg Lambrecht, founder and executive director of Intrinsic Therapeutics, with host Geoff Pardo to unpack why recurrent lumbar disc herniation is still so common, what surgeons and patients often don’t see downstream, and how his team built Barricaid to address the problem at its source: the annular defect. They also discuss the engineering logic of a bone-anchored barrier and why early “optimal” designs failed inside a body that’s anything but gentle, as well as CMS versus private payer incentives and why trial protocols should be negotiated with reimbursement stakeholders early. 

Subscribe and leave a review with your biggest question about getting breakthrough devices adopted. 

LINKS:      

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

Intrinsic Therapeutics Links:
Barricaid 

Brian Webster, President and CEO of Kestra Medical Technologies (Nasdaq: KMTS), joins Medtech Talk to discuss his 30-year career in cardiac defibrillation and the road to founding Kestra. With host Swaril Mathur, Webster unpacks learnings from leading through decades of repeated acquisitions, divestitures, and restructurings — and keeping the team motivated through it all. Their conversation explores what it takes to commercialize a rental fleet model with outsourced manufacturing, revenue cycle management, and payer contracts, as well as closing with the decision to IPO and staying steady in volatile markets by focusing on execution fundamentals. Subscribe, share this with a MedTech operator who’s scaling something hard, and leave a rating or review with the leadership lesson that hit you most. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

MicroTransponderLinks:
MicroTransponder 

Kestra Medical Technologies:
Kestra Medical Technologies 

How do you approach growing and investing? Quentin Blackford, president and CEO of iRhythm Technologies, joins Medtech Talk host Justin Klein to discuss how he took his company beyond traditional monitoring and expanded into the primary care setting, even though many traditional medical device companies don’t have much success in primary care. Blackford shares advice on how to develop expertise and comfort in approaching and embracing technology investment (particularly with AI), as well as his thoughts on how the medtech ecosystem is currently approaching the learning curve and tech adoption.

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare   

Vensana Capital: 
Vensana Capital 

iRhythm Links: 
iRhythm 

How do you evaluate investments and risks? Kate Garret, managing partner at Sonder, and Deborah Kilpatrick, partner at Sonder, share their insights and experiences as entrepreneurs, CEOs, and investors in this episode of Medtech Talk, hosted by Swaril Mathur. They deep dive into the practical realities of entrepreneurship, including the importance of networking, knowing when to keep pushing or pull out of an investment, making hard decisions, and how to conduct a successful shutdown. Garret and Kilpatrick also discuss their mentorship programs and offer advice for aspiring innovators on how to break into the industry.

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

MicroTransponderLinks: 
MicroTransponder 

Meeting the right people can completely change the trajectory of one’s career. In this episode of Medtech Talk, host Geoff Pardo speaks with Stacy Enxing Seng, independent director and venture partner, about her journey from Harvard Business School to SciMed to ev3 and beyond. She delves into the lessons learned, the challenges, and—most importantly—the people that have impacted her illustrious career. She also shares advice on why soft skills are key to acquisitions and integrations, the importance of transparency, and determining the difference between a CEO who isn’t the right fit versus a CEO who has room to grow. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare 
Corza Medical 
Lightstone Ventures 

The data gap in women’s health has always been a major issue and challenge. Ridhi Tariyal, CEO and co-founder of NextGen Jane, is on a mission to de-risk the women’s health field and fill in the blanks with critical information and research. Host Swaril Mathur speaks with Tariyal on how NextGen Jane is collecting data through menstrual blood to make diagnoses and treatments easier. Tariyal also shares advice on the pros and cons of going the cash-pay consumer route and pitching the right business proposal to gain investors’ attention, as well as NextGen’s plans and focus points. 

Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

MicroTransponderLinks:
MicroTransponder 

NextGen Jane: 
NextGen Jane 

From consulting to working at large companies to taking a risk with start-ups to becoming Silk Road Medical’s CEO, Chas McKhann has experienced almost everything in his long and illustrious career. In a discussion with Medtech Talk host Geoff Pardo, McKhann shares all the lessons learned from his jump to small private companies, handling a cultural rebirth as a newcomer CEO under the public eye, and taking on his role at Silk Road. He also talks about the “what if’s” of his journey and tips on surviving in the industry, as well as witnessing the market shift from only caring about revenue to wanting to see the path to capital break even. 

LINKS:
Medtech Talk Links: 
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare  

Silk Road Medical: 
Silk Road Medical 

Niche markets and small populations don’t get the attention they need for medtech and healthcare.  Medtech Talk host Swaril Mathur speaks with Eric Chehab, founder and former CEO of Novonate and director of business development of Laborie OB/GYN/NICU, and James Wall, pediatric surgeon and founder of Impact1 at Stanford University, about how they’re bringing medtech innovation to small patient populations. They delve into their experiences of founding their own niche market companies and the lessons learned, including how they navigated commercialization and acquisition processes, convinced the right investors, determined capital efficiency, and more. They also share their thoughts on investors who think niche solutions for niche markets are uninteresting. 

Medtech Talk Links:  
Cambridge Healthtech Institute   
Medtech Talk 
Gilde Healthcare 
MicroTransponderLinks:
MicroTransponder
Stanford University Links:
Stanford Healthcare
Stanford Medicine Children’s Health
Stanford University 

Laborie Links:
Laborie